A better pricing environment in the US, impending product launches, and prospects of superior profitability are also seen boosting the earnings of the company going ahead, analysts said.
Gland Pharma surges 20% as biz momentum seen turning
Date:
More like thisRelated
President Trump’s “Weaponization” Executive Order
President Trump signed another executive order, titled "Ending the...
Trump Signals a Crackdown on Legal and Illegal Immigration
The president plans to suspend refugee resettlement and declare...
Trump Goes After Mexico by Designating Drug Cartels Terrorist Organizations
Designating cartels as terrorist organizations could allow the feds...